Sucampo Pharmaceuticals, Inc. Appoints Kathryn de Santis as Vice President, Investor Relations and Corporate Communications

BETHESDA, MD--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc., (NASDAQ:SCMP), today announced that it has named Kathryn de Santis as its Vice President, Investor Relations and Corporate Communications.